37 results
ARS
2023 FY
CRBU
Caribou Biosciences Inc
25 Apr 24
Annual report to shareholders
4:06pm
), the rationale behind the enrollment goals, the subject patient population, potential barriers for enrollment, among others. This Table of Contents 36 … review. Once the submission has been accepted for filing, the FDA begins an in-depth review of the application. Under the goals and policies agreed
ARS
2022 FY
CRBU
Caribou Biosciences Inc
28 Apr 23
Annual report to shareholders
12:00am
, ethnic characteristics, age), the rationale behind the enrollment goals, the subject patient population, potential barriers for enrollment, among … to permit substantive review. Once the submission has been accepted for filing, the FDA begins an in-depth review of the application. Under the goals
DEF 14A
5tjd1wsd6 f73ydzdogd
11 Aug 22
Definitive proxy
4:04pm
10-K
EX-10.34
qduzh p4rb7
21 Mar 22
Annual report
4:19pm
10-K
EX-10.31
yxooda6x
21 Mar 22
Annual report
4:19pm
10-K
EX-10.36
rlh0zebdl4ljw66wzf
21 Mar 22
Annual report
4:19pm
10-K
EX-10.40
v1r3kdmsya
21 Mar 22
Annual report
4:19pm
10-K
r5zjkp0l
21 Mar 22
Annual report
4:19pm
10-K
EX-10.38
qcjov
21 Mar 22
Annual report
4:19pm
8-K
EX-10.1
vo7gbb0 xzqqfg98
19 Jan 22
Entry into a Material Definitive Agreement
4:19pm
S-8
EX-99.2
zg75tclmr441adgt
26 Jul 21
Registration of securities for employees
4:15pm
S-8
EX-99.6
jvxzue9xn9q7qi1o
26 Jul 21
Registration of securities for employees
4:15pm
S-8
EX-99.1
8eg3d
26 Jul 21
Registration of securities for employees
4:15pm
424B4
xoe47 ojrdvtin0sz
23 Jul 21
Prospectus supplement with pricing info
4:24pm
S-1/A
EX-10.41
g3wiqhcm67uxp
19 Jul 21
IPO registration (amended)
6:09am